指南与共识妇科

平等医疗系统中妇科癌症指南依从性治疗的种族-民族比较

Racial-Ethnic Comparison of Guideline-Adherent Gynecologic Cancer Care in an Equal-Access System.
指南 / 共识 · Obstet Gynecol · 2021-01-01

该研究基于MilCanEpi数据库,纳入1998至2014年确诊的3354例妇科癌症(子宫、宫颈、卵巢)女性,比较不同种族-民族接受NCCN指南依从性治疗的情况。总体77.8%接受了指南依从性治疗,非西班牙裔黑人患者接受指南依从性治疗的可能性边缘性低于非西班牙裔白人(aOR 0.73,95%CI 0.53-1.00,P=.011),且显著低于亚裔(aOR 0.65,95%CI 0.44-0.97)或西班牙裔(aOR 0.56,95%CI 0.34-0.92)。结论提示在平等医疗系统中,种族-民族差异仍存在,除医疗可及性外其他因素也贡献于差异。

要点

  • 非西班牙裔黑人患者接受指南依从性治疗的可能性边缘性低于非西班牙裔白人(aOR 0.73,95%CI 0.53-1.00,P=.011)。
  • 非西班牙裔黑人患者接受指南依从性治疗的可能性显著低于亚裔(aOR 0.65,95%CI 0.44-0.97)或西班牙裔(aOR 0.56,95%CI 0.34-0.92)。
  • 亚裔和西班牙裔与非西班牙裔白人相比,指南依从性治疗无显著差异。

核心结论

  • 在平等医疗的军事卫生系统中,妇科癌症指南依从性治疗存在种族-民族差异,提示除医疗可及性外其他因素也导致差异。

研究设计与样本

  • 采用多因素logistic回归模型比较非西班牙裔黑人、亚裔、西班牙裔与非西班牙裔白人女性接受指南依从性治疗的似然比,报告调整比值比(aOR)和95%置信区间(CI)。

主要发现

  • 总体77.8%的患者接受指南依从性治疗;非西班牙裔白人79.1%,亚裔75.9%,非西班牙裔黑人69.3%,西班牙裔80.5%。
  • 亚裔与非西班牙裔白人相比,接受指南依从性治疗的aOR为1.18(95%CI 0.84-1.48);西班牙裔与非西班牙裔白人相比,aOR为1.30(95%CI 0.86-1.96)。
  • 非西班牙裔黑人患者接受指南依从性治疗的可能性边缘性低于非西班牙裔白人(aOR 0.73,95%CI 0.53-1.00,P=.011),且显著低于亚裔(aOR 0.65,95%CI 0.44-0.97)或西班牙裔(aOR 0.56,95%CI 0.34-0.92)。

临床怎么用

  • 在平等医疗系统中,非西班牙裔黑人妇科癌症患者接受指南依从性治疗的可能性较低,临床应关注并减少潜在的不平等。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To compare receipt of National Comprehensive Cancer Network Guideline-adherent treatment for gynecologic cancers, inclusive of uterine, cervical, and ovarian cancer, between non-Hispanic White women and racial-ethnic minority women in the equal-access Military Health System. METHODS: We accessed MilCanEpi, which links data from the Department of Defense Central Cancer Registry and Military Health System Data Repository administrative claims data, to identify a cohort of women aged 18-79 years who were diagnosed with uterine, cervical, or ovarian cancer between January 1, 1998, and December 31, 2014. Information on tumor stage, grade, and histology was used to determine which treatment(s) (surgery, chemotherapy, radiotherapy) was indicated for each patient according to the National Comprehensive Cancer Network Guidelines during the period of the data (1998-2014). We compared non-Hispanic Black, Asian, and Hispanic women with non-Hispanic White women in their likelihood to receive guideline-adherent treatment using multivariable logistic regression models given as adjusted odds ratios (aORs) and 95% CIs. RESULTS: The study included 3,354 women diagnosed with a gynecologic cancer of whom 68.7% were non-Hispanic White, 15.6% Asian, 9.0% non-Hispanic Black, and 6.7% Hispanic. Overall, 77.8% of patients received guideline-adherent treatment (79.1% non-Hispanic White, 75.9% Asian, 69.3% non-Hispanic Black, and 80.5% Hispanic). Guideline-adherent treatment was similar in Asian compared with non-Hispanic White patients (aOR 1.18, 95% CI 0.84-1.48) or Hispanic compared with non-Hispanic White women (aOR 1.30, 95% CI 0.86-1.96). Non-Hispanic Black patients were marginally less likely to receive guideline-adherent treatment compared with non-Hispanic White women (aOR 0.73, 95% CI 0.53-1.00, P=.011) and significantly less likely to receive guideline-adherent treatment than either Asian (aOR 0.65, 95% CI 0.44-0.97) or Hispanic patients (aOR 0.56, 95% CI 0.34-0.92). CONCLUSION: Racial-ethnic differences in guideline-adherent care among patients in the equal-access Military Health System suggest factors other than access to care contributed to the observed disparities.

来源:Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Eaglehouse YL, Darcy KM, Tian C, et al. Racial-Ethnic Comparison of Guideline-Adherent Gynecologic Cancer Care in an Equal-Access System. Obstet Gynecol. 2021. PMID: 33706355. doi:10.1097/AOG.0000000000004325

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。